Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Free Cash Flow : -203.59M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -203.59M |
| March 31, 2026 | -449.64M |
| December 31, 2025 | -396.61M |
| September 30, 2025 | -460.43M |
| June 30, 2025 | -466.38M |
| March 31, 2025 | -422.14M |
| December 31, 2024 | -453.65M |
| September 30, 2024 | -473.07M |
| June 30, 2024 | -458.78M |
| March 31, 2024 | -778.97M |
| December 31, 2023 | -800.36M |
| September 30, 2023 | -668.37M |
| Date | Value |
|---|---|
| June 30, 2023 | -409.91M |
| March 31, 2023 | 928.33M |
| December 31, 2022 | 1.595B |
| September 30, 2022 | 1.567B |
| June 30, 2022 | 1.357B |
| March 31, 2022 | 555.04M |
| December 31, 2021 | -69.41M |
| September 30, 2021 | -148.52M |
| June 30, 2021 | -88.01M |
| March 31, 2021 | -237.98M |
| December 31, 2020 | -197.49M |
| September 30, 2020 | -153.44M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -1.244B |
| Vaxcyte, Inc. | -921.07M |
| Caribou Biosciences, Inc. | -95.75M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 123.33M |
| Cash from Investing (Quarterly) | -197.14M |
| Cash from Financing (Quarterly) | 78.38M |
| Free Cash Flow Per Share (Quarterly) | 0.7301 |
| Free Cash Flow to Equity (Quarterly) | 125.60M |
| Free Cash Flow to Firm (Quarterly) | 123.29M |
| Free Cash Flow Yield | -11.71% |